Martin Rud Pedersen

Martin Rud Pedersen has a comprehensive work experience in the pharmaceutical industry. Martin Rud began their career as a Clinical Research Associate at Wellcome Danmark A/S in 1992 and then moved to Novo Nordisk as a Clinical Development Scientist in 1994. Martin Rud joined Orion Corporation in 1997 as the Head of Clinical Development. In 2001, Martin joined ALK as the Director of Clinical Development. Martin Rud held various positions within ALK, including Acting Senior Vice President of Global Clinical Development and Senior Vice President of Global Pharmacovigilance & Clinical Development. Currently, Martin serves as the Vice President of Clinical Operations Strategy at ALK.

Martin Rud Pedersen completed a Managing Medical Product Innovation (MMPI) program at the Scandinavian International Management Institute (SIMI) in 2010. Prior to that, they obtained a M.Sc. degree in Pharmacy between 1982 and 1990.